|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
103,000,000 |
Market
Cap: |
515.00(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.99 - $9.1 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 13.2 |
Insider 6 Months : 13.2 |
Insider 3/6 Months : 26.2 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Humacyte is engaged in the development and manufacture of off-the-shelf, universally implantable, bioengineered human tissues. Co. is utilizing its technology platform to develop proprietary, bioengineered, acellular human tissues for use in the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
116,829 |
116,829 |
116,829 |
280,579 |
Total Buy Value |
$777,746 |
$777,746 |
$777,746 |
$1,397,147 |
Total People Bought |
4 |
4 |
4 |
7 |
Total Buy Transactions |
7 |
7 |
7 |
16 |
Total Shares Sold |
3,455,511 |
3,455,511 |
12,854,299 |
44,263,005 |
Total Sell Value |
$26,266,056 |
$26,266,056 |
$56,522,567 |
$146,898,591 |
Total People Sold |
3 |
3 |
4 |
4 |
Total Sell Transactions |
12 |
12 |
23 |
49 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Scheessele William John |
Chief Commercial Officer |
|
2022-12-13 |
4 |
B |
$3.09 |
$15,450 |
D/D |
5,000 |
15,525 |
2.74 |
20% |
|
Niklason Laura E |
President, CEO and Director |
|
2022-12-13 |
4 |
S |
$2.84 |
$937,200 |
I/I |
(330,000) |
18,600,004 |
|
-20% |
|
Prichard Heather Ledbetter |
Chief Operating Officer |
|
2022-12-12 |
4 |
OE |
$1.15 |
$7,549 |
D/D |
6,564 |
9,189 |
|
- |
|
Niklason Laura E |
President, CEO and Director |
|
2022-09-15 |
4 |
S |
$4.00 |
$6,090,000 |
I/I |
(1,522,500) |
18,930,004 |
|
32% |
|
Dougan Brady W |
Director |
|
2022-09-15 |
4 |
S |
$4.00 |
$6,090,000 |
I/I |
(1,522,500) |
18,930,004 |
|
32% |
|
Ayabudge Llc |
10% Owner |
|
2022-09-15 |
4 |
S |
$4.00 |
$6,090,000 |
D/D |
(1,522,500) |
18,930,004 |
|
32% |
|
Niklason Laura E |
President, CEO and Director |
|
2022-09-15 |
4 |
B |
$4.14 |
$8,280 |
D/D |
2,000 |
1,160,240 |
3.15 |
-32% |
|
Dougan Brady W |
Director |
|
2022-09-15 |
4 |
B |
$4.14 |
$8,280 |
I/I |
2,000 |
1,160,240 |
2.17 |
-32% |
|
Binder Gordon M |
Director |
|
2022-09-02 |
4 |
B |
$4.40 |
$272,100 |
D/D |
61,841 |
110,000 |
2.39 |
-41% |
|
Binder Gordon M |
Director |
|
2022-09-01 |
4 |
B |
$4.00 |
$192,636 |
D/D |
48,159 |
48,159 |
2.39 |
-40% |
|
Scheessele William John |
Chief Commercial Officer |
|
2022-05-24 |
4 |
B |
$4.72 |
$49,678 |
D/D |
10,525 |
10,525 |
2.74 |
-29% |
|
Dougan Brady W |
Director |
|
2022-05-23 |
4 |
B |
$4.83 |
$48,300 |
I/I |
10,000 |
1,158,240 |
2.25 |
-32% |
|
Niklason Laura E |
President, CEO and Director |
|
2022-05-23 |
4 |
B |
$4.83 |
$48,300 |
D/D |
10,000 |
1,158,240 |
3.23 |
-32% |
|
Constantino Michael T. |
Director |
|
2022-05-23 |
4 |
B |
$4.83 |
$9,660 |
D/D |
2,000 |
4,500 |
2.39 |
-32% |
|
Sander Dale A. |
CFO and Chief Corp. Deve. Off. |
|
2022-05-17 |
4 |
B |
$4.53 |
$9,060 |
D/D |
2,000 |
2,000 |
2.74 |
-27% |
|
Dougan Brady W |
Director |
|
2021-12-16 |
4 |
S |
$9.00 |
$675,000 |
D/D |
(75,000) |
510,161 |
|
15% |
|
Niklason Laura E |
President, CEO and Director |
|
2021-12-16 |
4 |
S |
$9.00 |
$675,000 |
I/I |
(75,000) |
510,161 |
|
15% |
|
Dougan Brady W |
Director |
|
2021-12-15 |
4 |
S |
$8.89 |
$1,110,625 |
D/D |
(125,000) |
585,161 |
|
18% |
|
Niklason Laura E |
President, CEO and Director |
|
2021-12-15 |
4 |
S |
$8.89 |
$1,110,625 |
I/I |
(125,000) |
585,161 |
|
18% |
|
Dougan Brady W |
Director |
|
2021-12-14 |
4 |
S |
$9.33 |
$943,707 |
D/D |
(100,000) |
710,161 |
|
19% |
|
Niklason Laura E |
President, CEO and Director |
|
2021-12-14 |
4 |
S |
$9.33 |
$943,707 |
I/I |
(100,000) |
710,161 |
|
19% |
|
Constantino Michael T. |
Director |
|
2021-11-22 |
4 |
B |
$10.79 |
$26,986 |
D/D |
2,500 |
2,500 |
2.39 |
-34% |
|
Fresenius Medical Care Holdings Inc /ny/ |
10% Owner |
|
2021-08-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,312,735 |
|
-48% |
|
Niklason Laura E |
President, CEO and DirectorOff |
|
2021-08-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
810,161 |
|
-48% |
|
Tente William Edward |
Chief Regulatory Officer |
|
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
52,519 |
52,519 |
|
- |
|
82 Records found
|
|
Page 3 of 4 |
|
|